Cefotaxime 2g powder for solution for injection vials

Страна: Великобритания

Язык: английский

Источник: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активный ингредиент:

Cefotaxime sodium

Доступна с:

Wockhardt UK Ltd

код АТС:

J01DD01

ИНН (Международная Имя):

Cefotaxime sodium

дозировка:

2gram

Фармацевтическая форма:

Powder for solution for injection

Администрация маршрут:

Intravenous; Intramuscular

класс:

No Controlled Drug Status

Тип рецепта:

Valid as a prescribable product

Обзор продуктов:

BNF: 05010201; GTIN: 5012727903378 5012727909219

тонкая брошюра

MEASURE BAR SHOULD BE 150MM AT 100% SCALE
Customer
Description
Item Code
Profile
Size
Min. Point Size
Market
Language
Proof By
Proof No.
Date
Artwork No.
Pharma
Code
Colours Used
[e-mail]
CLEARLY MARK ANY AMENDMENTS ON ONE PROOF AND RETURN TO MPS
WARNING! We cannot accept responsibility for any errors
in this proof after approval. Whilst we take extreme care
at all times to ensure accuracy to our clientʼs brief,
the final responsibility must be taken by our client.
IF YOU SIGN THIS PROOF YOU ARE SIGNIFYING
FULL APPROVAL OF DESIGN AND TEXT.
Process Black
Keyline (non-printing)
Wockhardt UK Limited
Cefotaxime common leaflet
106641/4
n-a
170 x 320mm
matt.pirie-scott
4
03/03/2017
831926
n-a
7pt (Main Body) / 7pt (Variables)
UK
English
PACKAGE LEAFLET: INFORMATION FOR THE USER
Cefotaxime 500mg powder for solution for injection or infusion
Cefotaxime 1g powder for solution for injection or infusion
Cefotaxime 2g powder for solution for injection or infusion
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TO TAKE THIS
MEDICINE.
-
Keep this leaflet. You may need to read it again while you are
receiving your treatment.
-
If you have any further questions, please ask your doctor or nurse.
-
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if their symptoms are the same as
yours.
-
If any of the side effects get serious, or if you notice any side
effects not listed in this leaflet, please tell your doctor or
pharmacist.
The name of your medicine is cefotaxime 500mg, 1g or 2g powder for
solution for injection or infusion. In the rest of this leaflet it is
called cefotaxime
for injection.
IN THIS LEAFLET:
1. What cefotaxime for injection is and what it is used for
2. Before you are given cefotaxime for injection
3. How cefotaxime for injection should be given
4. Possible side effects
5. How to store cefotaxime for injection
6. Further information
1.
WHAT CEFOTAXIME FOR INJECTION IS AND WHAT IT IS USED FOR
Cefotaxime belongs to a group of medicines called

Характеристики продукта

OBJECT 1
CEFOTAXIME 2G POWDER FOR SOLUTION FOR INJECTION
OR INFUSION
Summary of Product Characteristics Updated 15-Jun-2017 | Wockhardt UK
Ltd
1. Name of the medicinal product
Cefotaxime 2g Powder for solution for injection or infusion
2. Qualitative and quantitative composition
Each vial contains cefotaxime sodium equivalent to 2g of cefotaxime.
Each gram of cefotaxime contains approximately 48mg (2.09mmol) of
sodium.
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Powder for solution for injection or infusion (Powder for injection or
infusion).
White to slightly yellow powder.
4. Clinical particulars
4.1 Therapeutic indications
1. Cefotaxime is indicated in the treatment of serious infections,
either before the infecting organism has
been identified or when caused by bacteria of established sensitivity,
including
osteomyelitis,
septicaemia,
bacterial endocarditis,
meningitis, and
peritonitis.
and other serious bacterial infections suitable for parenteral
antibiotic therapy.
2. Cefotaxime may be used for pre-operative prophylaxis in patients
undergoing surgical procedures, that
may be classified as contaminated or potentially so.
4.2 Posology and method of administration
Cefotaxime may be administered intravenously, by bolus injection or by
infusion, or by intramuscular
injection. The dosage, route and frequency of administration should be
determined by the severity of
infection, the sensitivity of causative organisms and condition of the
patient. Therapy may be initiated
before the results of sensitivity tests are known.
Adults:
The recommended dosage for mild to moderate infections is 1g 12
hourly. However, dosage may be
varied according to the severity of the infection, sensitivity of
causative organisms and condition of the
patient. Therapy may be initiated before the results of sensitivity
tests are known.
In severe infections dosage may be increased up to 12g daily given in
three or four divided doses. For
infections caused by sensitive Pseudomonas species daily doses of
greater than